bioM eacute rieux Pharma Quality Control
 

« Previous article
AOAC® OMA Approval ...

18th June 2012  Content supplied by: 

New B. cereus Selective Agar BACARA in FDA BAM


AES CHEMUNEX, a bioMérieux Company is pleased to announce that the FDA BAM (Bacteriological Analytical Manual) Bacillus Chapter 14 has been updated with the inclusion of BACARA™ method for the detection and enumeration of Bacillus cereus in food samples.

BACARA™ is a proprietary chromogenic selective and differential agar, promoting the growth and identification of B. cereus. This medium inhibits greatly the growth of background flora.

BACARA is a recommended replacement of MYP agar thanks to improved selectivity and faster results, it also provides easy readings since typical colonies are pink-orange surrounded by a zone of precipitation. BACARA permits the identification of all species from the B.cereus group.

Visit www.biomerieux-industry.com/food/bacillus-cereus-culture-media for more information on Bacillus cereus culture medium.


Share on:

Tags:


Date Published: 18th June 2012


View full company details




bioMérieux (Pharma Quality Control)

Address:

Marcy L'Etoile

France

Tel: +[33] 4 78 87 20 00

Email Supplier

View full company details


Related news from bioMérieux (Pharma Quality Control)